Impact of risk minimisation measures on the use of strontium ranelate: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance
Үндсэн зохиолчид: | Berencsi, K, Ali, M, Marinier, K, Deltour, N, Hawley, S, Pedersen, L, Rijnbeek, P, Duijnhoven, R, Van Der Lei, J, Lapi, F, Simonetti, M, Reyes-Reyes, C, Sturkenboom, M, Prieto-Alhambra, D |
---|---|
Формат: | Conference item |
Хэвлэсэн: |
Wiley
2017
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Impact of risk minimisation measures on the use of strontium ranelate: A multinational cohort study in 5 EU countries by the EU‐ADR Alliance
-н: Berencsi, K, зэрэг
Хэвлэсэн: (2018) -
Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: a multi-database study in our European countries by the EU-ADR Alliance
-н: Ali, M, зэрэг
Хэвлэсэн: (2017) -
Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: A multi‐database study in 5 EU countries by the EU‐ADR Alliance
-н: Ali, M, зэрэг
Хэвлэсэн: (2018) -
A multi-database, multinational validation study of cardiovascular death, venous thromboembolic events and gastrointestinal diseases in the EU-ADR Alliance
-н: Ying, H, зэрэг
Хэвлэсэн: (2018) -
The impact of risk minimisation measures on the incidence and prevalence of use of strontium ranelate at the population level: preliminary results of a multi-national cohort study including 5 European countries
-н: Berencsi, K, зэрэг
Хэвлэсэн: (2016)